PUBLISHER: The Business Research Company | PRODUCT CODE: 1751044
PUBLISHER: The Business Research Company | PRODUCT CODE: 1751044
A medical high-pressure syringe is a specialized device used to inject contrast agents during imaging procedures such as CT and MRI scans. It is engineered to withstand the high pressures necessary for the rapid and controlled delivery of fluids, ensuring accurate dosing and improved imaging quality for diagnostic accuracy.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary product types of medical high-pressure syringes include CT injector systems, MRI injector systems, and angiographic injector systems. These contrast injectors are medical devices specifically designed to deliver contrast media into the body to enhance tissue visibility during imaging procedures. They are manufactured using various materials such as plastic, glass, and metal. Medical high-pressure syringes are utilized in a range of applications, including cardiology, radiology, urology, and orthopedics. Key end users of these devices include hospitals, diagnostic centers, and ambulatory surgical centers.
The medical high pressure syringe market research report is one of a series of new reports from The Business Research Company that provides medical high pressure syringe market statistics, including medical high pressure syringe industry global market size, regional shares, competitors with a medical high pressure syringe market share, detailed medical high pressure syringe market segments, market trends and opportunities, and any further data you may need to thrive in the medical high pressure syringe industry. This medical high pressure syringe market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The medical high pressure syringe market size has grown strongly in recent years. It will grow from$1.52 billion in 2024 to $1.65 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth during the historic period can be attributed to the increasing demand for diagnostic imaging procedures, the rising prevalence of chronic diseases, a surge in minimally invasive surgeries, greater adoption of contrast agents, and increased investments in healthcare infrastructure.
The medical high pressure syringe market size is expected to see strong growth in the next few years. It will grow to$2.26 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth during the forecast period can be attributed to the growing geriatric population, increased use of CT and MRI scans, rising demand for precision imaging, expanding access to healthcare in emerging markets, and a heightened focus on patient safety and injection accuracy. Major trends expected in this period include advancements in syringe automation technology, the use of advanced materials for improved durability, the development of dual-head and multi-head injectors, innovations in disposable syringe systems, and the emergence of integrated injector software solutions.
The rising demand for minimally invasive procedures is expected to drive the growth of the medical high-pressure syringes market in the near future. Minimally invasive procedures involve medical techniques that utilize small incisions or non-invasive methods to perform surgeries or treatments, resulting in less tissue damage, shorter recovery periods, and reduced postoperative pain compared to conventional surgical methods. The increase in these procedures is fueled by patients seeking quicker recovery and less invasive alternatives, as they generally lead to shorter hospital stays, fewer complications, and faster return to normal activities. Medical high-pressure syringes play a crucial role in supporting these procedures by delivering contrast media with precision and control, which is essential for accurate imaging and effective intervention. For example, in February 2024, the American Academy of Facial Plastic and Reconstructive Surgery, a US-based nonprofit organization, reported that 83% of all medical procedures performed in 2023 were minimally invasive, while only 17% were traditional surgeries. Additionally, the American Society of Plastic Surgeons, a US-based specialty group, noted that cosmetic minimally invasive procedures rose from 23.7 million in 2022 to 25.4 million in 2023. As a result, the increasing preference for minimally invasive procedures is significantly boosting the demand for medical high-pressure syringes.
Key players in the medical high-pressure syringes market are emphasizing the development of advanced technologies, such as needle-free systems, to improve patient safety and increase injection efficiency. Needle-free technology allows for the delivery of medications or fluids without traditional needles, aiming to reduce pain, lower the risk of infection, and encourage better patient compliance. For instance, in November 2024, Sol-Millennium Medical Group, a US-based medical company, launched a groundbreaking needle-free injection device for insulin delivery in Canada. This innovative solution is specifically designed to enhance patient comfort by eliminating the pain and fear typically associated with needle-based injections. Utilizing high-pressure technology, the device delivers insulin through the skin without piercing it. This advancement represents a major step forward in diabetes management, providing a more comfortable and accessible option for insulin users. The launch also signifies Sol-Millennium's strategic expansion into the Canadian medical device market.
In January 2022, ICU Medical Inc., a US-based medical technology company, completed the acquisition of Smiths Medical from Smiths Group plc for an undisclosed amount. The goal of this acquisition was to broaden ICU Medical's infusion therapy offerings and establish a robust, scalable platform that integrates complementary technologies across IV therapy, vascular access, and critical care. Smiths Group plc, based in the UK, is known for its range of products, including medical high-pressure syringes.
Major players in the medical high pressure syringe market are Cardinal Health Inc., Bayer AG, 3M Company, Medline Industries Inc., Becton Dickinson and Company, GE Healthcare Technologies Inc., Avantor Inc., Terumo Corporation, Gerresheimer AG, Merit Medical Systems Inc., MedNet GmbH, B. Braun Melsungen AG, Ulrich GmbH & Co. KG, Sino Medical-Device Technology Co. Ltd., Hawkmed (Shenzhen Hawk Medical Instrument Co. Ltd.), Kemper Medical Inc., Smiths Medical (a division of ICU Medical Inc.), APOLLO RT Co. Ltd., KD Scientific Inc., Hindustan Syringes & Medical Devices Limited.
North America was the largest region in the medical high pressure Syringe market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in medical high pressure syringe report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the medical high pressure syringe market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The medical high pressure syringe market consists of sales of CT high-pressure syringes, angiographic syringes, and automated injector-compatible syringes. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Medical High Pressure Syringe Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on medical high pressure syringe market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for medical high pressure syringe ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The medical high pressure syringe market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.